Join
Live feed
·
PRReleasevia Quantisnow
Immunome Inc. logo

Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

ByQuantisnow·Wall Street's wire, on your screen.
IMNM· Immunome Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMNM (Immunome Inc.) and more on Quantisnow.